These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34905534)

  • 1. A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
    Zens KD; Baroutsou V; Sinniger P; Lang P
    PLoS One; 2021; 16(12):e0247216. PubMed ID: 34905534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
    Steffen R; Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
    Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
    Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up.
    Beran J; Lattanzi M; Costantini M; Pammolli A; Galgani I
    Vaccine; 2023 May; 41(23):3518-3524. PubMed ID: 37142462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018.
    Baroutsou V; Zens KD; Sinniger P; Fehr J; Lang P
    Vaccine; 2020 Nov; 38(49):7825-7833. PubMed ID: 33164805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
    Beran J; Xie F; Zent O
    Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
    Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
    Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
    Beran J; Douda P; Gniel D; Zent O
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective, matched case-control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006-2020.
    Zens KD; Haile SR; Schmidt AJ; Altpeter ES; Fehr JS; Lang P
    BMJ Open; 2022 Apr; 12(4):e061228. PubMed ID: 35459683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study.
    Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2018 May; 9(4):768-777. PubMed ID: 29501619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBE--update on vaccination recommendations for children, adolescents, and adults.
    Jelinek T
    Wien Med Wochenschr; 2012 Jun; 162(11-12):248-51. PubMed ID: 22688621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with vaccination against tick-borne encephalitis virus in Germany.
    Jacob L; Kostev K
    Clin Microbiol Infect; 2017 Jul; 23(7):460-463. PubMed ID: 28143786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of TBE vaccination in southern Germany and Latvia.
    Erber W; Khan F; Zavadska D; Freimane Z; Dobler G; Böhmer MM; Jodar L; Schmitt HJ
    Vaccine; 2022 Jan; 40(5):819-825. PubMed ID: 34952753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
    Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
    Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.